XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Narrative) (Details) (USD $)
0 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended
Sep. 24, 2013
Mar. 31, 2014
employee
Mar. 31, 2014
Stock Option
Mar. 31, 2014
Restricted Stock
Mar. 31, 2014
Restricted Stock
Research and development
Mar. 31, 2014
Restricted Stock
General and administrative
Mar. 31, 2014
Common Stock
Mar. 31, 2014
Series C-1 Preferred Stock
Dec. 31, 2013
Series C-1 Preferred Stock
Mar. 31, 2014
Series C-1 Preferred Stock
Common Stock
Mar. 31, 2014
Series D-1 Preferred Stock
Common Stock
Mar. 31, 2014
Series F Preferred Stock
Dec. 31, 2013
Series F Preferred Stock
Mar. 31, 2014
Consultant
Restricted Stock
Mar. 31, 2014
Consultant
Common Stock
Sep. 24, 2013
2013 Equity Plan
Mar. 31, 2014
2013 Equity Plan
Jan. 02, 2014
2013 Equity Plan
Mar. 31, 2014
One-year Anniversary Date of Grant
Mar. 31, 2014
Quarterly
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                                        
Shares of common stock issued             2,852,626     2,797,029 52,621     2,976 2,976          
Preferred stock, shares authorized   8,000,000           11,000 11,000     10,000 10,000              
Preferred stock, par value   $ 0.0001           $ 0.0001 $ 0.0001     $ 0.0001 $ 0.0001              
Preferred stock, shares issued               5,393 7,016     3,066 3,250              
Equity plan, term 10 years                                      
Automatic annual increase based on outstanding shares of Common Stock as of the last day of the previous year end, percent                               10.00%        
Shares available for grant                                 367,441 422,441    
Number of employees granted stock options   5                                    
Options Granted, Number of Shares   55,000                                    
Award vesting rights, percentage                                     25.00%  
Period of share-based payment awards                                       3 years
Options Granted, Weighted-Average Exercise Price   $ 7.51                                    
Unamortized share-based compensation expense     $ 600,000                                  
Recognized weighted average period     44 months   22 months 32 months                            
Shares canceled       39,811                                
Unamortized share-based compensation expense         $ 2,189,000 $ 11,384,000